Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Cancer. 2019 Feb 15;125(11):1867–1876. doi: 10.1002/cncr.31995

Table 2:

Multivariable Analysis of 10 year progression free and overall survival across PFA ependymoma (n=60)

Progression Free Survival
p-value HR Lower CI 95% Upper CI 95%
Age 0.19 1.101 0.9534 1.27
Incomplete Resection 0.00599 ** 3.216 1.398 7.398
1995–2004 vs 2005–2014 0.31 0.576 0.1988 1.67
1985–1994 vs 2005–2014 0.9435 1.038 0.3665 2.942
Grade 3 vs 2 Histology 0.67 1.188 0.537 2.628
Upfront Radiation 4.2e-08 *** 30.72 9.029 104.5
Female Gender 0.538 1.264 0.599 2.665
Overall Survival
p-value HR Lower CI 95% Upper CI 95%
Age 0.51 0.94 0.7826 1.129
Incomplete Resection 0.273 1.665 0.6688 4.147
1995–2004 vs 2005–2014 0.2524 2.204 0.4536 8.535
1985–1994 vs 2005–2014 0.0493* 3.774 1.004 14.191
Grade 3 vs 2 Histology 0.198 1.909 0.713 5.116
Upfront Radiation 0.192 1.956 0.714 5.356
Female Gender 0.914 1.049 0.443 2.485